UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended December 27, 2014

or

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number: 001-36743

Apple Inc.

(Exact name of registrant as specified in its charter)

California

94-2404110

(State or other jurisdiction

of incorporation or organization)

(I.R.S. Employer Identification No.)

1 Infinite Loop

Cupertino, California

95014

(Address of principal executive offices)

(Zip Code)

(408) 996-1010

(Registrant s telephone number, including area code)

Indicate by check mark whether

the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports),

and (2) has been subject to such filing requirements for the past 90 days.

Yes No

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File

required to be submitted and posted pursuant to Rule 405 of Regulation S-T ( 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

Yes No

Indicate by check mark whether the registrant is a large

accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of large accelerated filer, accelerated filer and smaller reporting company in Rule 12b-2 of

the Exchange Act.

Large accelerated filer

Accelerated filer

Non-accelerated filer

(Do not check if a smaller reporting company)

Smaller reporting company

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes No

5,824,748,000 shares of common stock, par value $0.00001

per share, issued and outstanding as of January 9, 2015

Table of Contents

Apple Inc.

Form 10-Q

For the Fiscal Quarter Ended

December 27, 2014

TABLE OF CONTENTS

Page

Part I

Item 1.

Financial Statements

Item 2.

Management s Discussion and Analysis of Financial Condition and Results of Operations

24

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

38

Item 4.

Controls and Procedures

38

Part II

Item 1.

Legal Proceedings

39

Item 1A.

Risk Factors

40

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

50

Item 3.

Defaults Upon Senior Securities

50

Item 4.

Mine Safety Disclosures

50

Item 5.

Other Information

50

Item 6.

Exhibits

51

Table of Contents

PART I FINANCIAL INFORMATION

Item 1.

Financial Statements

Apple Inc.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)

(In millions, except number of shares which are reflected in thousands and per share amounts)

Three Months Ended

December 27,

2014

December 28,

2013

Net sales

74,599

57,594

Cost of sales

44,858

35,748

Gross margin

29,741

21,846

Operating expenses:

Research and development

1,895

1,330

Selling, general and administrative

3,600

3,053

Total operating expenses

5,495

4,383

Operating income

24,246

17,463

Other income/(expense), net

170

246

Income before provision for income taxes

24,416

17,709

Provision for income taxes

6,392

4,637

Net income

18,024

13,072

Earnings per share:

Basic

3.08

2.08

Diluted

3.06

2.07

Shares used in computing earnings per share:

Basic

5,843,082

6,272,504

Diluted

5,881,803

6,310,161

Cash dividends declared per common share

0.47

0.44

See accompanying Notes to Condensed Consolidated Financial Statements.

Table of Contents

Apple Inc.

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited)

(In millions)

Three Months Ended

December 27,

2014

December 28,

2013

Net income

18,024

13,072

Other comprehensive income/(loss):

Change in foreign currency translation, net of tax

(66

(67

Change in unrecognized gains/losses on derivative instruments:

Change in fair value of derivatives, net of tax

1,982

213

Adjustment for net losses/(gains) realized and included in net income, net of tax

(565

72

Total change in unrecognized gains/losses on derivative instruments, net of tax

1,417

285

Change in unrealized gains/losses on marketable securities:

Change in fair value of marketable securities, net of tax

(456

(42

Adjustment for net losses/(gains) realized and included in net income, net of tax

(14

(11

Total change in unrealized gains/losses on marketable securities, net of tax

(470

(53

Total other comprehensive income/(loss)

881

165

Total comprehensive income

18,905

13,237

See accompanying Notes to Condensed Consolidated Financial Statements.

Table of Contents

Apple Inc.

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)

(In millions, except number of shares which are reflected in thousands and par value)

December 27,

2014

September 27,

2014

ASSETS:

Current assets:

Cash and cash equivalents

19,478

13,844

Short-term marketable securities

12,985

11,233

Accounts receivable, less allowances of $87 and $86, respectively

16,709

17,460

Inventories

2,283

2,111

Deferred tax assets

5,046

4,318

Vendor non-trade receivables

13,267

9,759

Other current assets

13,635

9,806

Total current assets

83,403

68,531

Long-term marketable securities

145,492

130,162

Property, plant and equipment, net

20,392

20,624

Goodwill

4,629

4,616

Acquired intangible assets, net

4,370

4,142

Other assets

3,608

3,764

Total assets

261,894

231,839

LIABILITIES AND SHAREHOLDERS EQUITY:

Current liabilities:

Accounts payable

38,001

30,196

Accrued expenses

22,724

18,453

Deferred revenue

8,987

8,491

Commercial paper

3,899

6,308

Total current liabilities

73,611

63,448

Deferred revenue non-current

3,480

3,031

Long-term debt

32,504

28,987

Other non-current liabilities

28,971

24,826

Total liabilities

138,566

120,292

Commitments and contingencies

Shareholders equity:

Common stock and additional paid-in capital, $0.00001 par value: 12,600,000 shares authorized; 5,826,419 and 5,866,161 shares issued and

outstanding, respectively

24,187

23,313

Retained earnings

97,178

87,152

Accumulated other comprehensive income/(loss)

1,963

1,082

Total shareholders equity

123,328

111,547

Total liabilities and shareholders equity

261,894

231,839

See accompanying Notes to Condensed Consolidated Financial Statements.

Table of Contents

Apple Inc.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)

(In millions)

Three Months Ended

December 27,

2014

December 28,

2013

Cash and cash equivalents, beginning of the period

13,844

14,259

Operating activities:

Net income

18,024

13,072

Adjustments to reconcile net income to cash generated by operating activities:

Depreciation and amortization

2,575

2,144

Share-based compensation expense

888

681

Deferred income tax expense

2,197

1,253

Changes in operating assets and liabilities:

Accounts receivable, net

751

(1,098

Inventories

(172

(358

Vendor non-trade receivables

(3,508

(3,459

Other current and non-current assets

(1,648

(319

Accounts payable

9,003

8,191

Deferred revenue

945

1,368

Other current and non-current liabilities

4,667

1,195

Cash generated by operating activities

33,722

22,670

Investing activities:

Purchases of marketable securities

(44,915

(48,397

Proceeds from maturities of marketable securities

2,807

5,556

Proceeds from sales of marketable securities

24,166

30,302

Payments made in connection with business acquisitions, net

(23

(525

Payments for acquisition of property, plant and equipment

(3,217

(1,985

Payments for acquisition of intangible assets

(48

(59

Other

65

Cash used in investing activities

(21,165

(15,103

Financing activities:

Proceeds from issuance of common stock

80

134

Excess tax benefits from equity awards

264

280

Taxes paid related to net share settlement of equity awards

(512

(365

Dividends and dividend equivalents paid

(2,801

(2,769

Repurchase of common stock

(5,030

(5,029

Proceeds from issuance of long-term debt, net

3,485

Repayments of commercial paper, net

(2,409

Cash used in financing activities

(6,923

(7,749

Increase/(decrease) in cash and cash equivalents

5,634

(182

Cash and cash equivalents, end of the period

19,478

14,077

Supplemental cash flow disclosure:

Cash paid for income taxes, net

3,869

3,387

Cash paid for interest

202

161

See accompanying Notes to Condensed Consolidated Financial Statements.

Table of Contents

Apple Inc.

Notes to Condensed Consolidated Financial Statements (Unaudited)

Note 1 Summary of Significant Accounting Policies

Apple Inc. and its wholly-owned subsidiaries (collectively Apple or the Company ) designs, manufactures and

markets mobile communication and media devices, personal computers and portable digital music players, and sells a variety of related software, services, accessories, networking solutions and third-party digital content and applications. The Company

sells its products worldwide through its retail stores, online stores and direct sales force, as well as through third-party cellular network carriers, wholesalers, retailers and value-added resellers. In addition, the Company sells a variety of

third-party iPhone, iPad, Mac and iPod compatible products, including application software, and various accessories through its online and retail stores. The Company sells to consumers, small and mid-sized businesses and education, enterprise and

government customers.

Basis of Presentation and Preparation

The accompanying condensed consolidated financial statements include the accounts of the Company. Intercompany accounts and transactions have been

eliminated. The preparation of these condensed consolidated financial statements in conformity with U.S. generally accepted accounting principles ( GAAP ) requires management to make estimates and assumptions that affect the amounts

reported in these condensed consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates.

Certain prior period amounts in the notes to the condensed consolidated financial statements have been reclassified to conform to the current

period s presentation. In the first quarter of 2015, the Company changed its reportable operating segments and began allocating certain costs to its operating segments that were previously included in other corporate expenses. The Company has

reclassified the corresponding prior period amounts to conform to the current period s presentation as further described in Note 11, Segment Information and Geographic Data.

These condensed consolidated financial statements and accompanying notes should be read in conjunction with the Company s annual consolidated

financial statements and the notes thereto for the fiscal year ended September 27, 2014, included in its Annual Report on Form 10-K (the 2014 Form 10-K ). The Company s fiscal year is the 52 or 53-week period that ends on the

last Saturday of September. An additional week is included in the first fiscal quarter approximately every six years to realign fiscal quarters with calendar quarters. The Company s fiscal years 2015 and 2014 each include 52 weeks. Unless

otherwise stated, references to particular years, quarters or months refer to the Company s fiscal years ended in September and the associated quarters or months of those fiscal years.

Earnings Per Share

Basic earnings per share is computed by

dividing income available to common shareholders by the weighted-average number of shares of common stock outstanding during the period. Diluted earnings per share is computed by dividing income available to common shareholders by the

weighted-average number of shares of common stock outstanding during the period increased to include the number of additional shares of common stock that would have been outstanding if the potentially dilutive securities had been issued. Potentially

dilutive securities include outstanding stock options, shares to be purchased under the Company s employee stock purchase plan, unvested restricted stock and unvested restricted stock units ( RSUs ). The dilutive effect of potentially

dilutive securities is reflected in diluted earnings per share by application of the treasury stock method. Under the treasury stock method, an increase in the fair market value of the Company s common stock can result in a greater dilutive

effect from potentially dilutive securities.

The following table shows the computation of basic and diluted earnings per share for the three months

ended December 27, 2014 and December 28, 2013 (net income in millions and shares in thousands):

Three Months Ended

December 27,

2014

December 28,

2013

Numerator:

Net income

18,024

13,072

Denominator:

Weighted-average shares outstanding

5,843,082

6,272,504

Effect of dilutive securities

38,721

37,657

Weighted-average diluted shares

5,881,803

6,310,161

Basic earnings per share

3.08

2.08

Diluted earnings per share

3.06

2.07

Potentially dilutive securities whose effect would have been antidilutive were not significant for the three months ended

December 27, 2014 and December 28, 2013. The Company excluded these securities from the computation of diluted earnings per share.

Table of Contents

Note 2 Financial Instruments

Cash, Cash Equivalents and Marketable Securities

The following tables show the Company s cash and available-for-sale

securities adjusted cost, gross unrealized gains, gross unrealized losses and fair value by significant investment category recorded as cash and cash equivalents or short- or long-term marketable securities as of December 27, 2014 and

September 27, 2014 (in millions):

December 27, 2014

Adjusted

Cost

Unrealized

Gains

Unrealized

Losses

Fair

Value

Cash and

Cash

Equivalents

Short-Term

Marketable

Securities

Long-Term

Marketable

Securities

Cash

13,757

13,757

13,757

Level 1 (1):

Money market funds

3,346

3,346

3,346

Mutual funds

2,544

(159

2,385

2,385

Subtotal

5,890

(159

5,731

3,346

2,385

Level 2 (2):

U.S. Treasury securities

35,107

16

(58

35,065

545

692

33,828

U.S. agency securities

6,788

(11

6,779

582

291

5,906

Non-U.S. government securities

6,498

58

(105

6,451

177

6,274

Certificates of deposit and time deposits

2,778

2,778

272

1,168

1,338

Commercial paper

1,159

1,159

879

280

Corporate securities

92,371

159

(720

91,810

97

7,932

83,781

Municipal securities

939

(1

942

942

Mortgage- and asset-backed securities

13,501

32

(50

13,483

60

13,423

Subtotal

159,141

271

(945

158,467

2,375

10,600

145,492

Total

178,788

271

(1,104

177,955

19,478

12,985

145,492

September 27, 2014

Adjusted

Cost

Unrealized

Gains

Unrealized

Losses

Fair

Value

Cash and

Cash

Equivalents

Short-Term

Marketable

Securities

Long-Term

Marketable

Securities

Cash

10,232

10,232

10,232

Level 1 (1):

Money market funds

1,546

1,546

1,546

Mutual funds

2,531

(132

2,400

2,400

Subtotal

4,077

(132

3,946

1,546

2,400

Level 2 (2):

U.S. Treasury securities

23,140

15

(9

23,146

12

607

22,527

U.S. agency securities

7,373

(11

7,365

652

157

6,556

Non-U.S. government securities

6,925

69

(69

6,925

204

6,721

Certificates of deposit and time deposits

3,832

3,832

1,230

1,233

1,369

Commercial paper

475

475

166

309

Corporate securities

85,431

296

(241

85,486

6,298

79,182

Municipal securities

940

948

948

Mortgage- and asset-backed securities

12,907

26

(49

12,884

25

12,859

Subtotal

141,023

417

(379

141,061

2,066

8,833

130,162

Total

155,332

418

(511

155,239

13,844

11,233

130,162

(1)

The fair value of Level 1 securities is estimated based on quoted prices in active markets for identical assets or liabilities.

(2)

The fair value of Level 2 securities is estimated based on observable inputs other than quoted prices in active markets for identical assets and liabilities,

quoted prices for identical or similar assets or liabilities in inactive markets, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

Table of Contents

The Company may sell certain of its marketable securities prior to their stated maturities for

strategic reasons including, but not limited to, anticipation of credit deterioration and duration management. The net realized gains or losses recognized by the Company related to such sales were not significant during the three months ended

December 27, 2014 and December 28, 2013. The maturities of the Company s long-term marketable securities generally range from one to five years.

As of December 27, 2014 and September 27, 2014, gross unrealized losses related to individual securities that had been in a continuous loss

position for 12 months or longer were not significant.

As of December 27, 2014, the Company considers the declines in market value of its

marketable securities investment portfolio to be temporary in nature and does not consider any of its investments other-than-temporarily impaired. The Company typically invests in highly-rated securities, and its investment policy generally limits

the amount of credit exposure to any one issuer. The policy generally requires investments to be investment grade, with the primary objective of minimizing the potential risk of principal loss. Fair values were determined for each individual

security in the investment portfolio. When evaluating an investment for other-than-temporary impairment the Company reviews factors such as the length of time and extent to which fair value has been below its cost basis, the financial condition of

the issuer and any changes thereto, changes in market interest rates and the Company s intent to sell, or whether it is more likely than not it will be required to sell the investment before recovery of the investment s cost basis. During

the three months ended December 27, 2014 and December 28, 2013, the Company did not recognize any significant impairment charges.

Derivative Financial

Instruments

The Company uses derivatives to partially offset its business exposure to foreign currency and interest rate risk on expected future

cash flows, on net investments in certain foreign subsidiaries and on certain existing assets and liabilities. However, the Company may choose not to hedge certain exposures for a variety of reasons including, but not limited to, accounting

considerations and the prohibitive economic cost of hedging particular exposures. There can be no assurance the hedges will offset more than a portion of the financial impact resulting from movements in foreign currency exchange or interest rates.

To help protect gross margins from fluctuations in foreign currency exchange rates, certain of the Company s subsidiaries whose functional

currency is the U.S. dollar may hedge a portion of forecasted foreign currency revenue, and subsidiaries whose functional currency is not the U.S. dollar and who sell in local currencies may hedge a portion of forecasted inventory purchases not

denominated in the subsidiaries functional currencies. The Company may enter into forward contracts, option contracts or other instruments to manage this risk and may designate these instruments as cash flow hedges. The Company typically

hedges portions of its forecasted foreign currency exposure associated with revenue and inventory purchases, typically for up to 12 months.

To help

protect the net investment in a foreign operation from adverse changes in foreign currency exchange rates, the Company may enter into foreign currency forward and option contracts to offset the changes in the carrying amounts of these investments

due to fluctuations in foreign currency exchange rates. The Company designates these instruments as net investment hedges.

The Company may also

enter into non-designated foreign currency contracts to partially offset the foreign currency exchange gains and losses generated by the re-measurement of certain assets and liabilities denominated in non-functional currencies.

The Company may enter into interest rate swaps, options, or other instruments to manage interest rate risk. These instruments may offset a portion of

changes in income or expense, or changes in fair value of the Company s long-term debt or investments. The Company designates these instruments as either cash flow or fair value hedges. The Company s hedged interest rate transactions as of

December 27, 2014 are expected to be recognized within twelve years.

Cash Flow Hedges

The effective portions of cash flow hedges are recorded in accumulated other comprehensive income ( AOCI ) until the hedged item is recognized

in earnings. Deferred gains and losses associated with cash flow hedges of foreign currency revenue are recognized as a component of net sales in the same period as the related revenue is recognized, and deferred gains and losses related to cash

flow hedges of inventory purchases are recognized as a component of cost of sales in the same period as the related costs are recognized. Deferred gains and losses associated with cash flow hedges of interest income or expense are recognized in

other income/(expense), net in the same period as the related income or expense is recognized.

The ineffective portions and amounts excluded from

the effectiveness testing of cash flow hedges are recognized in other income/(expense), net. These amounts were not significant during the three months ended December 27, 2014 and December 28, 2013.

Table of Contents

Derivative instruments designated as cash flow hedges must be de-designated as hedges when it is

probable the forecasted hedged transaction will not occur in the initially identified time period or within a subsequent two-month time period. Deferred gains and losses in AOCI associated with such derivative instruments are reclassified

immediately into other income/(expense), net. Any subsequent changes in fair value of such derivative instruments are reflected in other income and expense unless they are re-designated as hedges of other transactions. The Company did not recognize

any significant net gains or losses related to the loss of hedge designation on discontinued cash flow hedges during the three months ended December 27, 2014 and December 28, 2013.

Net Investment Hedges

The effective portions of net investment

hedges are recorded in other comprehensive income ( OCI ) as a part of the cumulative translation adjustment. The ineffective portions and amounts excluded from the effectiveness testing of net investment hedges are recognized in other

income/(expense), net. These amounts were not significant during the three months ended December 27, 2014 and December 28, 2013.

Fair Value Hedges

Gains and losses related to changes in fair value hedges are recognized in earnings along with a corresponding loss or gain related to the change

in value of the underlying hedged item. The ineffective portions and amounts excluded from the effectiveness testing of fair value hedges recognized were not significant during the three months ended December 27, 2014 and December 28,

2013.

Non-Designated Derivatives

Derivatives that are not

designated as hedging instruments are adjusted to fair value through earnings in the financial statement line item to which the derivative relates. The net gains and losses recognized for foreign currency forward and option contracts not designated

as hedging instruments was not significant during the three months ended December 27, 2014 and December 28, 2013.

The Company records all

derivatives in the Condensed Consolidated Balance Sheets at fair value. The Company s accounting treatment for these derivative instruments is based on its hedge designation. The following tables show the Company s derivative instruments

at gross fair value as of December 27, 2014 and September 27, 2014 (in millions):

December 27, 2014

Fair Value of

Derivatives

Designated as

Hedge Instruments

Fair Value of

Derivatives Not

Designated as

Hedge Instruments

Total

Fair Value

Derivative assets (1):

Foreign exchange contracts

3,561

501

4,062

Interest rate contracts

201

201

Derivative liabilities (2):

Foreign exchange contracts

51

119

170

Interest rate contracts

87

87

September 27, 2014

Fair Value of

Derivatives

Designated as

Hedge Instruments

Fair Value of

Derivatives Not

Designated as

Hedge Instruments

Total

Fair Value

Derivative assets (1):

Foreign exchange contracts

1,332

222

1,554

Interest rate contracts

81

81

Derivative liabilities (2):

Foreign exchange contracts

41

40

81

(1)

The fair value of derivative assets is measured using Level 2 fair value inputs and is recorded as other current assets in the Condensed Consolidated Balance

Sheets.

(2)

The fair value of derivative liabilities is measured using Level 2 fair value inputs and is recorded as accrued expenses in the Condensed Consolidated Balance

Sheets.

10

Table of Contents